Document is current
Any future updates will be listed below
-
Authors
Isaksson, Johan https://orcid.org/0000-0003-1033-2618
Ruchkin, Vladislav https://orcid.org/0000-0002-2510-6798
Aho, Nikolas
Lundin Remnélius, Karl https://orcid.org/0000-0002-0270-8358
Marschik, Peter B. https://orcid.org/0000-0001-8932-0980
Bölte, Sven https://orcid.org/0000-0002-4579-4970
-
Funding
Funding for this research was provided by:
Vetenskapsrådet
VINNOVA
Svenska Forskningsrådet Formas
Hjärnfonden
Forskningsrådet om Hälsa, Arbetsliv och Välfärd
Stockholm Brain Institute
Autism and Asperger Association Stockholm
Queen Silvia Jubilee Fund
Stiftelsen Solstickan
PRIMA Child and Adult Psychiatry
the Pediatric Research Foundation at Astrid Lindgren Children’s Hospital
Stiftelsen för Strategisk Forskning
Stiftelsen Sven Jerrings Fond
Svenska Frimurarorden
Stiftelsen Kempe-Carlgrenska Fonden
Stiftelsen Sunnerdahls Handikappfond
Jeanssons Stiftelser
EU-AIMS
the Innovative Medicines Initiative Joint Undertaking (115300)
European Union’s Seventh Framework Programme
Karolinska Institute
- License Information
-
More Information
Article History
Received: 20 October 2021
Accepted: 26 January 2022
First Online: 19 February 2022
Declarations
:
: This study was approved by the National Swedish Ethical Review Board and written and oral informed consent was obtained from all participants after the nature of the study procedure had been fully explained.
: All subjects involved in both methods have provided informed consent for publication.
: The authors declare no conflict of interest related to this study. Bölte discloses that he has in the last 3 years acted as an author, consultant or lecturer for Medice and Roche. He receives royalties for textbooks, diagnostic and intervention tools from Hogrefe, Kohlhammer and UTB. Bölte is shareholder in SB Education and Psychological Consulting AB and NeuroSupportSolutions International AB.
